Your browser doesn't support javascript.
loading
Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience.
Califano, Daniela; Russo, Daniela; Scognamiglio, Giosuè; Losito, Nunzia Simona; Spina, Anna; Bello, Anna Maria; Capiluongo, Anna; Galdiero, Francesca; De Cecio, Rossella; Bevilacqua, Simona; Gargiulo, Piera; Marchesi, Edoardo; Canevari, Silvana; Perrone, Francesco; Daniele, Gennaro; De Cecco, Loris; Mezzanzanica, Delia; Pignata, Sandro.
Affiliation
  • Califano D; Functional Genomic Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • Russo D; Functional Genomic Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • Scognamiglio G; Surgical Pathology Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • Losito NS; Surgical Pathology Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • Spina A; Functional Genomic Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • Bello AM; Functional Genomic Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • Capiluongo A; Functional Genomic Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • Galdiero F; Functional Genomic Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • De Cecio R; Surgical Pathology Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • Bevilacqua S; Clinical Trials Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • Gargiulo P; Clinical Trials Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • Marchesi E; Integrated Biology Platform, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, 20133 Milan, Italy.
  • Canevari S; Molecular Therapies Unit, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, 20133 Milan, Italy.
  • Perrone F; Clinical Trials Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • Daniele G; Clinical Trials Unit, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
  • De Cecco L; Integrated Biology Platform, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, 20133 Milan, Italy.
  • Mezzanzanica D; Molecular Therapies Unit, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, 20133 Milan, Italy.
  • Pignata S; Urogynaecological Medical Oncology Unit Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", 80131 Naples, Italy.
Cells ; 9(4)2020 04 07.
Article in En | MEDLINE | ID: mdl-32272732
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Precision Medicine Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: Cells Year: 2020 Document type: Article Affiliation country: Italy Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Precision Medicine Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: Cells Year: 2020 Document type: Article Affiliation country: Italy Country of publication: Switzerland